Longitudinal changes in serological immune responses for NY-ESO-1 and XAGE-1.
Antibody responses in the phase Ib trial were analyzed for NY-ESO-1 (a) and XAGE-1 (b) in patients with positive antibody responses at baseline or during the KW-0761 treatment.(TIF)Click here for additional data file.